Nonmotor symptoms as presenting complaints in Parkinson’s disease: a clinicopathological study

O'Sullivan, Sean S., Williams, David R., Gallagher, David A., Massey, Luke A., Silveira‐Moriyama, Laura, Lees, Andrew J.·2008·Movement Disorders

Cited by (290)

Items 201–290 of 290

  1. Pain and Paresthesia in Parkinson's Disease
    Shen‐Yang Lim, Andrew H. Evans · 2011 · Parkinson s Disease
  2. Clinical Spectrum of Non-motor Symptoms in Correlation with Quality of Life in Parkinson’s Disease and Atypical Parkinsonism: Evidence in Reaching Consensus
    Madhusudan Tapdia, Anand Kumar, Ajay Kumar Yadav, Varun Kumar Singh, Abhishek Pathak, Rameshwar Nath Chaurasia, Vijaya Nath Mishra, Navneet Kumar Dubey, Neetu Rani Dhiman, Monika Shailesh et al. · 2025 · Annals of Neurosciences
  3. Combining QSAR and Molecular Docking for the Methodological Design of Novel Radiotracers Targeting Parkinson’s Disease
    Juan A. Castillo‐Garit, Mar Soria-Merino, Karel Mena‐Ulecia, Mónica Romero Otero, Virginia Pérez-Doñate, Francisco Torrens, Facundo Pérez‐Giménez · 2025 · Applied Sciences
  4. Defining Premotor Parkinson’s Disease: A Window of Opportunity for neuroprotection?
    Philipp Mahlknecht, Werner H Poewe · 2013 · Neurodegenerative Disease Management
  5. Beyond Visual Assessment of Basal Ganglia Uptake: Can Automated Method and Pineal Body Uptake Assessment Improve Identification of Nigrostriatal Dysfunction on 18F-DOPA PET/CT?
    Shir Hazut Krauthammer, Dan Cohen, Einat Even‐Sapir, Hedva Lerman · 2023 · International Journal of Molecular Sciences
  6. Clinically assessing cognitive function in Parkinson's disease
    Megan C. Bakeberg, Maddeson Riley, Michelle L. Byrnes, Frank Louis Mastaglia, Ryan S. Anderton · 2020 · Elsevier eBooks
  7. The neurobiology of the spinal cord in experimental parkinsonism and Parkinson's disease.
    Michela Ferrucci, Francesca Biagioni, Giorgio Vivacqua, Carla Letizia Busceti, Alessia Bartalucci, Paola Soldani, Loredana D’Este, Lorenzo Fumagalli, Francesco Fornai · 2013 · PubMed
  8. Adult Endogenous Dopaminergic Neuroregeneration Against Parkinson’s Disease: Ideal Animal Models?
    Yuganthini Vijayanathan, Siong Meng Lim, Maw Pin Tan, Fei Tieng Lim, Abu Bakar Abdul Majeed, Kalavathy Ramasamy · 2020 · Neurotoxicity Research
  9. Pain Medicine in Older Adults: How Should It Differ?
    Debra K. Weiner, Jordan F. Karp, Cheryl Bernstein, Natalia E. Morone · 2014 · Springer eBooks
  10. Behavioral, Cellular and Molecular Responses to Cold and Mechanical Stimuli in Rats with Bilateral Dopamine Depletion in the Mesencephalic Dopaminergic Neurons
    Mennatallah Elshennawy, Omar Ouachikh, Youssef Aissouni, Shahira Youssef, Shahira S. Zaki, Franck Durif, Aziz Hafidi · 2021 · Neuroscience
  11. What are the non-motor symptoms of Parkinson’s disease?
    К. Ray Chaudhuri, Niall Patrick Quinn · 2009 · Oxford University Press eBooks
  12. Effect of clinical autonomic dysfunction on cognitive functions in Parkinson’s disease
    Dursun Aygün, Çetin Kürşad Akpınar, Serpil Kıroğlu Yön, Musa Kazım Onar · 2017 · Dicle Medical Journal / Dicle Tip Dergisi
  13. An overview of pain in Parkinson's disease
    Panagiotis Zis, Elisaveta Sokolov, К. Ray Chaudhuri · 2016
  14. Nonmotor symptoms in Parkinson's disease: are we still waiting for the honeymoon?
    Carlo Colosimo, Roongroj Bhidayasiri · 2016 · European Journal of Neurology
  15. Evaluation of frequency of depression in a subset of population with idiopathic parkinsonism in a tertiary care hospital
    Aijaz Ali, Shafqat Hussain Mahar, Dileep J.S. Kumar, Meraj Fatima, Saira Abbas, Samar Iltaf, Muhammad Sohaib Asghar · 2021 · Romanian Journal of Neurology
  16. HOW THE FREQUENCY OF PAIN IN THE EARLY STAGES OF PARKINSON’S DISEASE AFFECTS THE SPEED OF DIAGNOSIS
    Bedia Samancı, Nazlı Durmaz Çelik, Başar Bılgıç, Serhat Özkan, Hasmet Ayhan Hanagasi · 2022 · Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi
  17. Trait Impulsivity as a Feature of Parkinson’s Disease Treatment and Progression
    Holly Spencer, Ryan S. Anderton · 2024 · Parkinson s Disease
  18. Chronic Pain in People with Physically Disabling Conditions: A Review of the Application of Biopsychosocial Models
    Kathryn Nicholson · 2012 · InTech eBooks
  19. Management of Nonmotor Symptoms of Parkinson's Disease
    Néstor Gálvez-Jiménez, Hubert H. Fernandez, Alberto Javier Espay, Susan Helen Fox · 2016 · Cambridge University Press eBooks
  20. Neuroprotective Effects of Metformin Versus Selegiline on Parkinson’s Disease Model By Reserpine through the Interrelation of α Synuclein and Antioxidants on Behavioral Changes in Rats
    Ghada Farouk Soliman, Ghada Hashem, Monica Gamal Fawzy, Walaa Ibrahim · 2019 · Egyptian Journal of Basic and Clinical Pharmacology
  21. Non-motor symptoms in patients with Parkinson’s disease in Babol, North of Iran
    Seyed Mohammad Masood Hojjati, Arman Farrasat, Hoda Naghshineh, Ali Alizadeh Khatir, Alijan Ahmadi Ahangar, Payam Saadat, Shayan Alijanpour · 2019 · Romanian Journal of Neurology
  22. Pain Medicine in Older Adults: How Should It Differ?
    Debra K. Weiner, Jordan F. Karp, Cheryl Bernstein, Natalia E. Morone · 2012 · Springer eBooks
  23. Análise de redes de interação transcricional na substância nigra, locus cerúleo e núcleo dorsal do nervo vago na Doença de Parkinson
    Beatriz Raposo Corradini · 2013 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  24. Nonmotor Problems in Parkinson Disease
    Stanley Fahn, Joseph J. Jankovic, Mark Hallett, Peter G. Jenner · 2007 · Elsevier eBooks
  25. The association between blood urea nitrogen to albumin ratio and cognitive function in Parkinson’s disease patients
    Wen Zhou, Qingqing Xia, Duan Liu, Tian-fang Zeng, Rui-juan Pang, Junying Li, Liang Gong · 2026 · Frontiers in Neurology
  26. Psychotropic medication use among community dwellers with and without Parkinson's disease – A nationwide cohort study
    Noora Nieminen, Anna‐Maija Tolppanen, Valtteri Kaasinen, Marjaana Koponen, Sirpa A. Hartikainen · 2026 · British Journal of Clinical Pharmacology
  27. Baicalein alleviates anxiety symptom in Parkinson’s disease by targeting Sema3A-mediated parvalbumin interneuron dysfunction
    Yixiao Dong, Xinyue Zhang, Xinle Zhou, Kunkun Zhao, Xina Yang, Qianwen Li, Guanhua Du, Xuemei Qin · 2026 · Phytomedicine
  28. Heterogeneous pathologies associated with dementia in Parkinsonism share a prion-like spreading mechanism.
    Serena Candela, Franco Giubilei, Francesco Orzi · 2013 · PubMed
  29. La douleur dans la maladie de Parkinson
    Christine Brefel‐Courbon, Fabienne Ory‐Magne · 2010 · Neurologie com
  30. Manifestaciones psiquiátricas en la enfermedad de Parkinson: a propósito de un caso
    es Rodolfo Eduardo Pezoa Jares · 2012
  31. Features of dementia as non-motor symptom of Parkinson's disease.
    A. F. Toma, Petru MIHANCEA · 2014
  32. Veränderungen der spinalen und supraspinalen Schmerzwahrnehmung bei Patienten mit M. Parkinson
    Standort Marburg · 2009
  33. Aging with Parkinson’s Disease
    Joe R. Nocera, Keith McGregor · 2018 · Handbooks in health, work, and disability
  34. Advances in Stem Cell Research for Parkinson Disease
    Irmgard B. Paris, Ulises Ahumada-Castro, Juan Segura‐Aguilar · 2014 · Springer eBooks
  35. La douleur dans la maladie de Parkinson
    Julia Dupouy, Fabienne Ory‐Magne, Christine Brefel‐Courbon · 2016 · Douleur et Analgésie
  36. Spectrum of non motor symptoms (NMS) in Parkinson's disease patients and correlating them with the severity of motor symptoms- a South Indian study
    G Sangamithra, NS Sampath Kumar, Ganesh Vallampalli, Pns Prasad · 2019 · Journal of Neurology & Stroke
  37. Research Progress on Acupuncture Treatment of Motor and Nonmotor Symptoms in Parkinson’s Disease
    中秋 李 · 2020 · Traditional Chinese Medicine
  38. Nonmotor problems in Parkinson disease
    Stanley Fahn, Joseph J. Jankovic, Mark Hallett · 2011 · Elsevier eBooks
  39. Central Nervous System Pain
    Hisham Salahuddin, Mehari Gebreyohanns · 2020 · Springer eBooks
  40. Effects of Aminoadamantane Derivatives on Morphine-Induced Analgesia in Mice
    Л. Г. Колик, Анна Владимировна Надорова, I. V. Chernyakova, Елена Артуровна Вальдман · 2020 · Pharmaceutical Chemistry Journal
  41. Study of cognitive impairment and genetic polymorphism of SLC41A1 (rs11240569 allele) in Parkinson’s disease in Upper Egypt: case-control study
    Hamdy N. El-Tallawy, Tahia Hashim Saleem, Wafaa M. A. Farghaly, Heba M. Saad Eldien, Ashraf Khodaery, Sherif A. Sayed, Ahmed A. Helaly, Hassan Mohammed Elnady · 2021 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
  42. Signes non moteurs
    Jean‐Philippe Azulay, Tatiana Witjas · 2020 · Elsevier eBooks
  43. Anxiety Syndromes and Panic Attacks
    Daniel A. Weintraub, Staci Hoops · 2011 · Parkinson s Disease
  44. "A GREAT PERTURBATION IN NATURE" : PARKINSON'S DISEASE AND SLEEP DISORDERS
    Ari Ylikoski · 2016 · Työväentutkimus Vuosikirja
  45. Predictive Modeling to Uncover Parkinson’s Disease Characteristics That Delay Diagnosis
    Tom Hähnel, Tamara Raschka, Jochen Klucken, Enrico Glaab, Jean‐Christophe Corvol, Björn H. Falkenburger, Holger Fröhlich · 2024 · medRxiv
  46. The proteomic approach to investigate Parkinson's desease: pathogenetic mechanisms and biomarkers discovery.
    Tiziana Alberio · 2010 · IrInSubria (University of Insubria)
  47. Depression and Movement Disorders
    Oliver Tüscher, Ludger Tebartz van Elst · 2012 · Wiley eBooks
  48. Specific neuropsychiatric disorders
    Dag Aarsland, Jeffrey L. Cummings, Daniel Weintraub, К. Ray Chaudhuri · 2013 · Cambridge University Press eBooks
  49. Conséquences du changement d’horaire saisonnier chez le patient atteint de la maladie de Parkinson
    Damien Fetter, Romain Lefaucheur, Stéphane Derrey, David Maltête · 2013 · Revue Neurologique
  50. DeNoPa Kassel: Die prospektive Langzeit-Follow-up-Studie zu Biomarkern und nicht-motorischen Symptomen bei Morbus Parkinson - Pilotstudie baseline
    Stefanie Werner · 2012
  51. Schmerzwahrnehmung und Schmerzempfindung bei Progressiver Supranukleärer Blickparese (PSP)
    Helena Dohmann · 2013 · open_UMR Marburg DSpace 10.0 (Philipps-Universität Marburg)
  52. Original Article The impact of DaTscan on the diagnosis and management of movement disorders: A retrospective study
    Kimberly D. Seifert, Jonathan I Wiener · 2013
  53. Disfunción no motora en la enfermedad de Parkinson: una enfermedad neurológica con manifestaciones multisistémicas
    Amin Cervantes‐Arriaga, Mayela Rodríguez‐Violante · 2011 · Medicina Interna de México
  54. Treatment of Moderate Parkinson’s Disease
    John E. Duda, Matthew Stern · 2012 · CRC Press eBooks
  55. Parkinson’s Disease: Premotor Features, Diagnosis, and Early Management
    Anthony H.V. Schapira, David A. Gallagher · 2013
  56. Comorbid Neurological Illness
    Dylan P. Wint, Jeffrey L. Cummings · 2013 · Oxford University Press eBooks
  57. Management of pain and neuromuscular complications in Parkinson's disease
    John Anthony Morren · 2016 · Cambridge University Press eBooks
  58. Nonmotor symptoms in Parkinson's
    Anna Hussl, Klaus Seppi · 2013
  59. Non-motor Symptom Management in Parkinson’s Disease
    EDUARDO S. TOLOSA, Carles Gaig, Lillian Acevedo · 2013
  60. Effects of α/β/γ-Synuclein overexpression on the mitochondria and viability of neurons, examined using genetically encoded fluorescent sensors
    Johan Toloe · 2014
  61. Autonomic function and non-motor symptoms in primary chronic autonomic failure disorders
    Ekawat Vichayanrat · 2014
  62. The Assessment of Non-Motor Symptoms in Idiopathic Parkinson’s Disease
    Fatma Genç, Abidin Erdal, Yasemin Bıçer Gömceli, Aysun Tiltak, Cenk Altunç, Levent Renda, Gülnihal Kutlu · 2017 · Medeniyet Medical Journal
  63. Efeitos de um treino de marcha associado à prática mental sobre o desempenho da marcha em pacientes com doença de Parkinson
    Anelise dos Santos Rodrigues · 2018
  64. Does conjunctive tissue massage increase range of motion in muscles with plastic hypertonia due to Parkinson's disease?
    Carolina Menezes Fiorelli, Amanda Camargo da Silva, Alexandre Fiorelli, Tiago Penedo, Fabiana Araújo Silva, Fábio Augusto Barbieri · 2020 · Brazilian Journal of Motor Behavior
  65. Clinical Trials on Management of Pain in Parkinson’s Disease
    Azman Aris, Katarina Rukavina, Raquel N. Taddei, Alexandra Rizos, Anna Sauerbier, К. Ray Chaudhuri · 2020 · Neuromethods
  66. Neuroinflammatory mechanisms and translational approaches in environmental neurotoxicity models
    Colleen Elizabeth Jeffrey · 2012
  67. Nonmotor problems in Parkinson disease
    Joseph J. Jankovic, Mark Hallett, Michael S. Okun, Cynthia L. Comella, Stanley Fahn, Jennifer G. Goldman · 2021 · Elsevier eBooks
  68. Parkinson's disease
    Jiang‐Fan Chen · 2012 · Cambridge University Press eBooks
  69. Паркинсон касаллигида беморларнинг адаптатив хусусиятларини баҳолаш
    Сожида Жалилова, Бобир Кураматов · 2020 · Общество и инновации
  70. Longitudinale strukturelle MRT zur Untersuchung der Hirnatrophie von Patienten mit Morbus Parkinson und kognitiver Beeinträchtigung
    Florian David Seitz · 2022
  71. Burning chest pain as a prodromal sign in autopsy- proven Parkinson’s disease dementia
    Dallah Yoo, Sung-Hye Park, Man Jin Kim, Tae‐Beom Ahn · 2022 · Neurology Asia
  72. Motor and autonomic disorders influence on pain syndrome of patients with Parkinson’s disease of the I—III H&Y stages
    Anna A. Pilipovich, Vorob'eva Ov · 2023 · S S Korsakov Journal of Neurology and Psychiatry
  73. Risk Factors of Non-motor Symptoms in Different Stages of Parkinson’s Disease
    Jinlan Jiang, Wei Jin, Zhaoshun Lv, Zi tong Xu, Fengling Liang, Lihong Li · 2023 · Research Square
  74. Estudo prospectivo aleatorizado para avaliar a eficácia e a segurança da estimulação magnética da medula espinhal na dor nociceptiva em pacientes com doença de Parkinson
    Jorge Dornellys da Silva Lapa · 2023
  75. A propagação de formas pré-fibrilares de alfa-sinucleína entre células enteroendócrinas e neuronais é dependente de contato célula-célula e de Rab35
    Paulla Vieira Rodrigues · 2021
  76. Clinical Profile of Parkinson Disease at a Tertiary Care Centre
    Naveen Reddy B, Mythri Ambavaram · 2023 · International Journal of Science and Research (IJSR)
  77. Association Between Serum Uric Acid Level and the Severity of Parkinsons Disease: A cross sectional study
    Muhammad Shamsul Islam, Khan Md Nazmus Saqeb · 2024 · Bangladesh Critical Care Journal
  78. Machine Learning Based Parkinson’s Disease Detection Using Voice and Handwriting Analysis
    Sauransh Singh, Ruchir Kumar Kadwey, S. Krishna Srivatsava, Shikhar Singh, M R Shrisha · 2024 · Transactions on computer systems and networks
  79. Depression in Parkinson’s Disease: A Trajectory Linking Gut Microbiota and Neuroinflammation
    Punit Prasanna Kujur, Manas Ranjan Sahu, Amal Chandra Mondal · 2024 · Integrated science
  80. The Effect of Cognitive Impairments in Parkinson’s Disease on Caregiver Burden
    Sena Kıcıklar · 2025 · IBAD Sosyal Bilimler Dergisi
  81. Further characterisation of the intrastriatal 6-OHDA Parkinson's disease model with non-motor symptom replication and widespread catecholamine dysfunction in male mice
    Alisha Braun, Jessica Racz, Sanjay Garg, Larisa Bobrovskaya · 2025 · Neurochemistry International
  82. Estudio del sistema nervioso autónomo en la enfermedad de Parkinson y otras alfasinucleinopatías
    Judith Navarro‐Otano · 2014 · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
  83. Non-motor and neuropsychiatric features of Parkinson's disease
    David A. Gallagher · 2013 · UCL Discovery (University College London)
  84. Occupational risk factors for Parkinson disease
    Marianne van der Mark · 2014 · Utrecht University Repository (Utrecht University)
  85. Parkinson’s disease biomarkers: bridging the gap between diagnosis and treatment
    Vaibhav A Chakkarwar, Yogesh Anant Kulkarni · 2026 · Behavioural Brain Research
  86. La queue de l’aire tegmentale ventrale : définition anatomo-moléculaire, implication dans la réponse aux stimuli aversifs et influence sur la voie nigrostriée
    Fanny Faivre · 2018
  87. A study of different structures of central nervous system implicated in Parkinson’s disease neuropathic pain
    Mennatallah Elshennawy · 2021
  88. Progressive orexin A positive neuron loss in the 6-OHDA mouse model of Parkinson’s disease: a pilot study with validation of an orexin A immunohistochemistry protocol for paraffin-embedded tissue
    Alisha Braun, Phat Tai Vo, Larisa Bobrovskaya · 2026 · Brain Research
  89. The role of botulinum toxin in the multimodal management of pain in Parkinson’s disease: a scoping review
    Bo Biering‐Sørensen, Jörg Wissel, Tanya Gurevich, Alain Kaelin‐Lang, Igor N. Petrović, Zvezdan Pirtošek, Vladana Marković, Monika Rudzińska, Ivan Gospodinov Milanov · 2026 · Journal of Neural Transmission
  90. Pain and sensory abnormalities in prodromal and early Parkinson's disease: mechanisms, assessment, and clinical implications
    Maria Skallerup Andersen, Lorenz Oppel, Boris Modrau, Kimmo Jensen, Parisa Gazerani · 2026 · Frontiers in Pain Research